Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
USING OZONOTHERAPY ON THE TREATMENT OF EYE DISEASES
(LITERATURE REVIEW)
Bekmurodova Orzigul Kamolovna
Senior Lecturer of the Department of Ophthalmology, Bukhara State Medical Institute
named after Abu Ali Ibn Sino, Bukhara, Uzbekistan.
ORCID: https://orcid.org/0009-0000-9931-973X
Abstract
. Ozonetherapy is gaining attention in ophthalmology as a potential treatment for
various eye conditions due to its anti-inflammatory, bactericidal, and circulatory benefits.
Early uses in veterinary medicine show promise, particularly for anterior segment diseases,
suggesting ozone could help reduce inflammation and infections in the eye. Studies and
reviews have explored ozone therapy's application for eye diseases, noting different methods
for administration, such as topical use and systemic delivery. Evidence suggests it may be
effective for age-related macular degeneration (AMD), with some studies indicating
improvements in visual acuity. Ozone therapy is also examined for other inflammatory
conditions and wound healing, but has possible side effects, like burning eyes. While ozone
can be beneficial, environmental exposure can worsen dry eye symptoms. Stabilized
ozonated oils may offer a safer application for treatment. More extensive clinical trials are
needed to establish standardized protocols and ensure safe usage.
Key words:
Ozonetherapy, dry eye syndrome, anterior segment, age-related macular
dystrophy.
Introduction
Ozonetherapy has garnered increasing interest within ophthalmology as a potential adjunct
or alternative treatment modality for various eye conditions. The therapeutic application of
ozone, primarily due to its anti-inflammatory, bactericidal, and circulatory-enhancing
properties, has been explored across multiple studies and clinical reports, highlighting both
its potential benefits and associated risks.
One of the earliest documented uses of ozone in ocular treatment is its application in anterior
segment pathologies, particularly in veterinary medicine. According to [1], ozone-based eye
drops have been employed in cases involving anterior segment diseases, with promising
outcomes attributed to ozone’s anti-inflammatory and bactericidal activities. This suggests
that ozone could serve as a topical agent to mitigate inflammation and combat infections in
the eye, which are common features in many ocular diseases.
Further elaborating on the therapeutic scope, [2] provides a comprehensive overview
of ozone therapy in ophthalmology, listing various eye diseases and the recommended
methods for local ozone application. The review emphasizes that ozone therapy can be
administered through different routes, including topical application, insufflation,
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
and systemic administration, tailored to specific conditions. The authors underscore the
importance of proper dosing and application techniques to maximize benefits and
minimize adverse effects.
Clinical evidence supporting the efficacy of ozonotherapy in ocular conditions is presented
in studies focusing on age-related degenerative diseases. Notably, [3] reports on two small
clinical studies involving 217 patients with dry age-related macular degeneration (AMD).
The findings suggest that ozonetherapy may halt disease progression and improve visual
acuity, indicating a potential role for ozone in managing degenerative retinal conditions.
These results are particularly significant given the limited treatment options available for
AMD, especially in its early stages.
In addition to degenerative diseases, ozone therapy has been explored for its anti-
inflammatory effects in other ocular conditions. [4] discusses the broader context of ozone
therapy, noting its potential to heal wounds and treat various diseases, including ocular
inflammations. However, the authors also caution about possible side effects, such as
burning eyes and coughing, which are associated with ozone exposure. This highlights the
need for careful administration and monitoring during therapy.
Holistic approaches to eye care, incorporating ozone therapy, are also documented. [5,6]
Describes how ozone therapy can be integrated into treatment plans for dry eye syndrome
and inflammatory conditions, emphasizing its role in reducing inflammation and supporting
tissue healing. The authors advocate for ozone as part of a comprehensive, patient-centered
approach, although they acknowledge that more extensive clinical trials are necessary to
establish standardized protocols.
The impact of environmental ozone exposure on ocular health is addressed in [7], which
reports that ambient ozone, a common air pollutant, can exacerbate dry eye symptoms. This
underscores a paradox where ozone, beneficial when used therapeutically, can be harmful in
environmental contexts, contributing to ocular surface damage and inflammation. Such
findings highlight the importance of controlled ozone application in clinical settings.
The anti-inflammatory properties of ozone are further supported by studies on stabilized
ozone derivatives. [8] describes the use of ozonated oils, which can be effectively stabilized
for topical use. These formulations have shown promise in reducing ocular surface
inflammation, offering a safer and more manageable means of delivering ozone’s
therapeutic effects. This approach could mitigate some of the risks associated with gaseous
ozone exposure.
Emerging evidence also points to the potential of ozone therapy in treating degenerative
retinal diseases such as macular degeneration. [9] Presents a recent study
from Cuba indicating that ozone therapy may reverse some effects of macular degeneration,
a leading cause of vision loss in the elderly. Similarly, [10] discusses observations of ozone
therapy applied to dystrophic maculopathy, suggesting that alterations in ocular tissue health
may be modifiable through ozone treatment. These findings are preliminary but suggest a
promising avenue for future research into degenerative retinal conditions.
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
Despite these encouraging reports, caution is warranted. [7] emphasizes that ozone,
particularly in environmental exposure, can worsen dry eye symptoms and cause ocular
irritation. This duality underscores the importance of controlled, therapeutic use of ozone, as
opposed to uncontrolled environmental exposure, which can be detrimental.
Conclusion.
In summary, the current div of literature indicates that ozonetherapy holds potential as a
multifaceted treatment modality in ophthalmology. Its anti-inflammatory, antimicrobial, and
circulatory benefits could be harnessed to manage a variety of eye diseases, including dry
eye syndrome, inflammatory conditions, and degenerative diseases such as age-related
macular degeneration (AMD) and maculopathy. Nonetheless, the evidence remains
preliminary, and further rigorous clinical trials are necessary to establish standardized
treatment protocols, optimal dosing, and safety profiles. The dual nature of ozone—
therapeutic when properly administered and harmful when exposure is uncontrolled—
necessitates careful application and ongoing research to elucidate its role in eye disease
management fully.
REFERENCES
1.
Spadea L, Tonti E, Spaterna A, Marchegiani A. Use of Ozone-Based Eye Drops: A
Series of Cases in Veterinary and Human Spontaneous Ocular Pathologies. Case Rep
Ophthalmol. 2018 May 24;9(2):287-298. doi: 10.1159/000488846. PMID: 29928225;
PMCID: PMC6006625.
2.
Borrelli E, Bocci V. Visual improvement following ozonetherapy in dry age related
macular degeneration; a review. Med Hypothesis Discov Innov Ophthalmol. 2013
Summer;2(2):47-51. PMID: 24600642; PMCID: PMC3939750.
3.
Riva Sanseverino, E., Meduri, R. A., Pizzino, A., Prantera, M., & Martini, E. (1990).
Effects
of
oxygen-ozone
therapy
on
age-related
degenerative
retinal
maculopathy.
Panminerva medica
,
32
(2), 77–84.
4.
Kim, Y., Paik, H. J., Kim, M. K., Choi, Y. H., & Kim, D. H. (2019). Short-Term
Effects of Ground-Level Ozone in Patients With Dry Eye Disease: A Prospective Clinical
Study.
Cornea
,
38
(12), 1483–1488. https://doi.org/10.1097/ICO.0000000000002045
5.
Seen, S., & Tong, L. (2018). Dry eye disease and oxidative stress.
Acta
ophthalmologica
,
96
(4), e412–e420. https://doi.org/10.1111/aos.13526
6.
Aydoğan, S., Erol, H., & Baran, M. (2023). Effects of ozone therapy on acidic
corneal burns in rats.
Veterinary research forum : an international quarterly journal
,
14
(4),
195–199. https://doi.org/10.30466/vrf.2022.551199.3432
7.
Travagli V. (2022). Some clarifications regarding ozone therapy vs retinal vascular
reactivity.
Photodiagnosis
and
photodynamic
therapy
,
40
,
103140.
https://doi.org/10.1016/j.pdpdt.2022.103140
8.
Kaya, A., Sonmez, M., Kar, T., Haholu, A., Yildirim, Y., Müftüoğlu, T., & Ünal, M.
H. (2017). Efficiency of Ozone Therapy in a Rat Model of Experimental Uveitis.
Ocular
immunology
and
inflammation
,
25
(5),
695–700.
https://doi.org/10.3109/09273948.2016.1161057
9.
Varol, K., Koç, A. N., Çakır Bayram, L., Arda, H., Keleş, İ., Ünlü, M., Güneş, V.,
Ekinci, G., Karaca Bekdik, İ., & Atalay, M. A. (2022). Studies on the Effectiveness of
Ozone Therapy on the Treatment of Experimentally Induced Keratitis with
Candida
Vo
lu
m
e
5,
Ju
ne
,2
02
5
,
M
ED
IC
AL
SC
IE
N
CE
S.
IM
PA
CT
FA
CT
OR
:7
,8
9
albicans
in
Rabbits.
Seminars
in
ophthalmology
,
37
(2),
253–264.
https://doi.org/10.1080/08820538.2021.1995006
10.
Gierek-Lapińska, A., Antoszewski, Z., Myga, B., & Skowron, J. (1992). Wstepne
doniesienie o stosowaniu ozonoterapii ogólnej w schorzeniach tylnego bieguna gałki ocznej
[Preliminary report on using general ozone therapy in diseases of the posterior segment of
the
eye].
Klinika
oczna
,
94
(5-6),
139–140.
